Dapagliflozin (10mg Tab)
Sponsors
Yung NA, Centenario Hospital Miguel Hidalgo, Hospital de Clinicas de Porto Alegre, University of Edinburgh, Seug yun Yoon, MD
Conditions
Acute Heart Failure (AHF)AdolescentAlbuminuriaAnemiaAngina With Non-Obstructive Coronary Artery DiseaseChronic Kidney Disease (Mild to Moderate)Congestive Heart Failure AcuteCoronary Microvascular Dysfunction (CMD)
Phase 2
Dapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate Cancer
Not yet recruitingNCT07310433
Start: 2026-06-01End: 2030-10-30Target: 60Updated: 2025-12-30
POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure
Not yet recruitingNCT07469722
Start: 2026-03-23End: 2028-07-01Target: 128Updated: 2026-03-18
Dapagliflozin for Anemia in Lower-Risk Myelodysplastic Syndromes
Not yet recruitingNCT07516847
Start: 2026-09-01End: 2029-09-01Target: 37Updated: 2026-04-08
Dapagliflozin in Living-Donor Kidney Transplant Recipients
Active, not recruitingNCT07555106
Start: 2024-09-15End: 2026-09-30Updated: 2026-04-29
Effects of Dapagliflozin, Semaglutide, and Their Combination in Heart Failure Patients With Prosthetic Heart Valves
CompletedNCT07610174
Start: 2025-06-02End: 2026-04-29Updated: 2026-05-29
aDAPt-ANOCA: Dapagliflozin for the Treatment of Angina With Non-Obstructive Coronary Artery Disease (ANOCA)
Not yet recruitingNCT07741890
Start: 2026-09-01End: 2029-03-01Target: 120Updated: 2026-08-03
Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome
Not yet recruitingNCT07810998
Start: 2026-09-10End: 2027-05-10Target: 60Updated: 2026-09-09
Phase 4
Unknown Phase
Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy
RecruitingNCT07491718
Start: 2025-08-08End: 2028-08-09Target: 100Updated: 2026-03-24
DP-DCT 1.0:A Comparative Clinical Study on the Effect of Dapagliflozin Combined With CGM Versus SMBG on Glycemic Control in Patients With Type 2 Diabetes Mellitus Based on the DP-DCT Platform
Not yet recruitingNCT07595289
Start: 2026-08-01End: 2027-08-01Target: 120Updated: 2026-05-19